Growth suppressive effect of pegylated arginase in malignant pleural mesothelioma xenografts
Abstract Background Malignant pleural mesothelioma (MPM) is a difficult-to-treat global disease. Pegylated arginase (BCT-100) has recently shown anti-tumor effects in hepatocellular carcinoma, acute myeloid leukemia and melanoma. This study aims to investigate the effects of PEG-BCT-100 in MPM. Meth...
Main Authors: | Sze-Kwan Lam, Yuan-Yuan Li, Shi Xu, Leanne Lee Leung, Kin-Pong U, Yan-Fang Zheng, Paul Ning-Man Cheng, James Chung-Man Ho |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-05-01
|
Series: | Respiratory Research |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12931-017-0564-3 |
Similar Items
-
Metabolic therapy with PEG-arginase induces a sustained complete remission in immunotherapy-resistant melanoma
by: Carmela De Santo, et al.
Published: (2018-05-01) -
Disturbance of the Warburg effect by dichloroacetate and niclosamide suppresses the growth of different sub-types of malignant pleural mesothelioma in vitro and in vivo
by: Sze-Kwan Lam, et al.
Published: (2022-10-01) -
The Chick Embryo Xenograft Model for Malignant Pleural Mesothelioma: A Cost and Time Efficient 3Rs Model for Drug Target Evaluation
by: Sarah E. Barnett, et al.
Published: (2022-11-01) -
Establishment and Characterization of Patient-Derived Xenografts (PDXs) of Different Histology from Malignant Pleural Mesothelioma Patients
by: Roberta Affatato, et al.
Published: (2020-12-01) -
Malignant pleural mesothelioma
by: Rao Sukhesh
Published: (2009-01-01)